| Description | Lumiliximab (IDEC-152) is a primate-ized chimeric antibody targeting CD23 rhesus monkey/human chimeric antibody with inhibitory effects on IgE antibody production for the study of allergic diseases. |
| Synonyms | IDEC-152, ST-152 |
| molecular weight | N/A |
| CAS | 357613-86-6 |
| Storage | store at low temperature | store at -80°C |
| References | 1. Poole JA, et al. Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects. J Allergy Clin Immunol. 2005 Oct;116(4):780-8. |